Division of Translational Cancer Research
301 – 310 of 588
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Anti-tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL-302 in neuroblastoma
(
- Contribution to journal › Article
-
Mark
Prediction of lymph node metastasis in breast cancer by gene expression and clinicopathological models: Development and validation within a population based cohort.
(
- Contribution to journal › Article
-
Mark
Agreement between molecular subtyping and surrogate subtype classification: a contemporary population-based study of ER-positive/HER2-negative primary breast cancer
(
- Contribution to journal › Article
-
Mark
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer
(
- Contribution to journal › Article
-
Mark
Multinodal high throughput acoustic trapping of exosomes from urine samples
2019) 23rd International Conference on Miniaturized Systems for Chemistry and Life Sciences, MicroTAS 2019 In 23rd International Conference on Miniaturized Systems for Chemistry and Life Sciences, MicroTAS 2019 p.2-3(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Cyclophilin Inhibitor NV556 Reduces Fibrosis and Hepatocellular Carcinoma Development in Mice With Non-Alcoholic Steatohepatitis
(
- Contribution to journal › Article
-
Mark
A cryptic non-GPI-anchored cytosolic isoform of CD59 controls insulin exocytosis in pancreatic β-cells by interaction with SNARE proteins
2019) In FASEB journal : official publication of the Federation of American Societies for Experimental Biology 33(11). p.12425-12434(
- Contribution to journal › Article
- 2018
-
Mark
Hypoxia and hypoxia-inducible factors in neuroblastoma
(
- Contribution to journal › Article
-
Mark
Integrin αVβ3 can substitute for collagen-binding β1-integrins in vivo to maintain a homeostatic interstitial fluid pressure
(
- Contribution to journal › Article
-
Mark
De novo activating mutations drive clonal evolution and enhance clonal fitness in KMT2A-rearranged leukemia
(
- Contribution to journal › Article